Peter M. Thulé

2.5k total citations
44 papers, 2.0k citations indexed

About

Peter M. Thulé is a scholar working on Surgery, Molecular Biology and Genetics. According to data from OpenAlex, Peter M. Thulé has authored 44 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Surgery, 21 papers in Molecular Biology and 15 papers in Genetics. Recurrent topics in Peter M. Thulé's work include Pancreatic function and diabetes (19 papers), Diabetes and associated disorders (11 papers) and Diabetes Management and Research (10 papers). Peter M. Thulé is often cited by papers focused on Pancreatic function and diabetes (19 papers), Diabetes and associated disorders (11 papers) and Diabetes Management and Research (10 papers). Peter M. Thulé collaborates with scholars based in United States, China and Canada. Peter M. Thulé's co-authors include Darin E. Olson, Machelle T. Pardue, Edward A. Phelps, Andrés J. Garcı́a, Moon Kim, W. Robert Taylor, Guillermo E. Umpierrez, Moe H. Aung, Natalia Landázuri and Timothy Q. Duong and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Neuroscience and Gastroenterology.

In The Last Decade

Peter M. Thulé

43 papers receiving 2.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Peter M. Thulé United States 26 818 587 450 409 337 44 2.0k
Young Suk Yu South Korea 32 1.4k 1.7× 160 0.3× 976 2.2× 78 0.2× 206 0.6× 124 3.1k
Chiung‐Chyi Shen Taiwan 30 762 0.9× 660 1.1× 39 0.1× 482 1.2× 65 0.2× 152 2.9k
Yang Hu China 27 1.0k 1.2× 142 0.2× 688 1.5× 121 0.3× 443 1.3× 80 2.3k
Hiroshi Inoué Japan 29 1.0k 1.2× 652 1.1× 56 0.1× 135 0.3× 259 0.8× 188 3.2k
Jiajun Xu China 24 730 0.9× 156 0.3× 71 0.2× 81 0.2× 73 0.2× 87 1.6k
Keisuke Okabe Japan 19 618 0.8× 212 0.4× 89 0.2× 77 0.2× 85 0.3× 73 1.7k
Utako Yokoyama Japan 33 1.5k 1.8× 384 0.7× 22 0.0× 96 0.2× 155 0.5× 112 3.1k
Naoki Otani Japan 27 695 0.8× 480 0.8× 47 0.1× 155 0.4× 36 0.1× 211 2.9k
Denis Calise France 31 1.2k 1.4× 1.0k 1.7× 20 0.0× 132 0.3× 217 0.6× 74 3.4k
Rong‐Kung Tsai Taiwan 24 488 0.6× 373 0.6× 751 1.7× 45 0.1× 35 0.1× 132 1.7k

Countries citing papers authored by Peter M. Thulé

Since Specialization
Citations

This map shows the geographic impact of Peter M. Thulé's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter M. Thulé with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter M. Thulé more than expected).

Fields of papers citing papers by Peter M. Thulé

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter M. Thulé. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter M. Thulé. The network helps show where Peter M. Thulé may publish in the future.

Co-authorship network of co-authors of Peter M. Thulé

This figure shows the co-authorship network connecting the top 25 collaborators of Peter M. Thulé. A scholar is included among the top collaborators of Peter M. Thulé based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter M. Thulé. Peter M. Thulé is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Allen, Rachael S, et al.. (2019). Retinal Deficits Precede Cognitive and Motor Deficits in a Rat Model of Type II Diabetes. Investigative Ophthalmology & Visual Science. 60(1). 123–123. 25 indexed citations
2.
You, Shuo, Mallappa Anitha, Xianghua Lu, et al.. (2015). Hepatic insulin gene therapy prevents diabetic enteropathy in STZ-treated CD-1 mice. Molecular Therapy — Methods & Clinical Development. 2. 15028–15028. 4 indexed citations
3.
Aung, Moe H., Han Na Park, Tracy S. Obertone, et al.. (2014). Dopamine Deficiency Contributes to Early Visual Dysfunction in a Rodent Model of Type 1 Diabetes. Journal of Neuroscience. 34(3). 726–736. 126 indexed citations
4.
Thulé, Peter M., et al.. (2014). Therapeutic Effects of a Non–β Cell Bioartificial Pancreas in Diabetic Mice. Transplantation. 98(5). 507–513. 3 indexed citations
5.
Pardue, Machelle T., Claire S. Barnes, Moon Kim, et al.. (2014). Rodent Hyperglycemia-Induced Inner Retinal Deficits are Mirrored in Human Diabetes. Translational Vision Science & Technology. 3(3). 6–6. 54 indexed citations
6.
Aung, Moe H., Xiaodong Zhang, Han Na Park, et al.. (2013). Role of Dopamine Deficiency in Visual Dysfunction in Early-stage Diabetic Retinopathy. Investigative Ophthalmology & Visual Science. 54(15). 1143–1143. 2 indexed citations
7.
Phelps, Edward A., Kellie L. Templeman, Peter M. Thulé, & Andrés J. Garcı́a. (2013). Engineered VEGF-releasing PEG–MAL hydrogel for pancreatic islet vascularization. Drug Delivery and Translational Research. 5(2). 125–136. 97 indexed citations
8.
Aung, Moe H., Moon Kim, Peter M. Thulé, & Machelle T. Pardue. (2012). Assessing Flicker-induced Retinal Vascular Responses using Scanning Laser Ophthalmoscope. Investigative Ophthalmology & Visual Science. 53(14). 5434–5434. 1 indexed citations
9.
Thulé, Peter M., et al.. (2011). Combinatorial insulin secretion dynamics of recombinant hepatic and enteroendocrine cells. Biotechnology and Bioengineering. 109(4). 1074–1082. 3 indexed citations
10.
Nair, Govind, Moon Kim, Tsukasa Nagaoka, et al.. (2011). Effects of common anesthetics on eye movement and electroretinogram. Documenta Ophthalmologica. 122(3). 163–176. 73 indexed citations
11.
Thulé, Peter M.. (2010). Dinamarca: tradición y modernidad: vínculos entre la arquitectura danesa de los siglos XIX y XX. QRU Quaderns de Recerca en Urbanisme. 28–33.
12.
Zhang, Jin‐an, et al.. (2009). Hepatic insulin gene therapy diminishes liver glycogen despite insulin responsive transcriptional effects in diabetic CD‐1 mice. The Journal of Gene Medicine. 11(7). 588–597. 5 indexed citations
13.
Olson, Darin E., et al.. (2008). Hepatic Insulin Gene Therapy Normalizes Diurnal Fluctuation of Oxidative Metabolism in Diabetic BB/Wor Rats. Molecular Therapy. 16(7). 1235–1242. 10 indexed citations
14.
Mwangi, Simon M., Mallappa Anitha, Xiaokun Ding, et al.. (2008). Glial Cell Line-Derived Neurotrophic Factor Increases β-Cell Mass and Improves Glucose Tolerance. Gastroenterology. 134(3). 727–737. 39 indexed citations
15.
Hwang, Jinah, Dean J. Kleinhenz, Heidi L. Rupnow, et al.. (2007). The PPARγ ligand, rosiglitazone, reduces vascular oxidative stress and NADPH oxidase expression in diabetic mice. Vascular Pharmacology. 46(6). 456–462. 90 indexed citations
16.
Thulé, Peter M., et al.. (2000). Regulated hepatic insulin gene therapy of STZ-diabetic rats. Gene Therapy. 7(20). 1744–1752. 87 indexed citations
17.
Thulé, Peter M., Jun Liu, & Lawrence S. Phillips. (2000). Glucose regulated production of human insulin in rat hepatocytes. Gene Therapy. 7(3). 205–214. 84 indexed citations
18.
Ziemer, David C., Merilyn G. Goldschmid, Victoria C. Musey, et al.. (1996). Diabetes in urban african americans. III. Management of type II diabetes in a municipal hospital setting. The American Journal of Medicine. 101(1). 25–33. 45 indexed citations
19.
Huang, Sheng‐Xiong, Peter M. Thulé, & Lawrence S. Phillips. (1995). Identification of Novel Promoter and Repressor Elements in the 5′-Flanking Regions of the Rat Insulin-like Growth-Factor-I Gene. Biochemical and Biophysical Research Communications. 206(1). 279–286. 9 indexed citations
20.
Zincke, Horst, David C. Utz, Peter M. Thulé, & William F. Taylor. (1987). Treatment options for patients with stage D1 (T0-3,N1-2,M0) adenocarcinoma of prostate. Urology. 30(4). 307–315. 66 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Young Suk Yu Breakdown of academic impact, for papers by Chiung‐Chyi Shen Breakdown of academic impact, for papers by Yang Hu Breakdown of academic impact, for papers by Hiroshi Inoué Breakdown of academic impact, for papers by Jiajun Xu Breakdown of academic impact, for papers by Keisuke Okabe Breakdown of academic impact, for papers by Utako Yokoyama Breakdown of academic impact, for papers by Naoki Otani Breakdown of academic impact, for papers by Denis Calise Breakdown of academic impact, for papers by Rong‐Kung Tsai
Rankless by CCL
2026